跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 144,955 条关于
“Sun Yat-Sen University Cancer Center”
全部
144,955
临床试验
110,787
药物
6,208
机构
4,520
资讯
23,440
11个月前
DNMT Inhibitors Combined with Anti-PD-1 Therapy Show Promise for Refractory NK/T-Cell Lymphoma
去年
Antengene's Selinexor Shows Promise in Multiple Myeloma and Lymphoma Studies
2年前
Radiation Therapy Alone Shows Promise in Low-Risk Nasopharyngeal Carcinoma
去年
Perioperative Toripalimab Improves Outcomes in Nasopharyngeal Carcinoma
去年
Antengene to Present Selinexor Data in Relapsed/Refractory Multiple Myeloma and Extranodal NK/T-Cell Lymphoma at ASH 2024
去年
Antengene to Present Selinexor Data from Two Late-Stage Studies at ASH 2024
去年
Antengene to Present Selinexor Data from Phase III Multiple Myeloma and Phase I/II Lymphoma Studies at ASH 2024
去年
Real-World Analysis Reveals Cardiac Failure Risk Varies Significantly Among Breast Cancer Therapies
去年
Antengene to Present Selinexor Data from Late-Stage Trials at ASH 2024
去年
Henlius Presents Promising Data on Serplulimab and HLX22 at ASCO GI 2025
第 1 页，共 2344 页
上一页
下一页
